橡楚编辑部 38 min read
Medical grade liquid silicone rubber overmolding is a core process suitable for medical consumables, implantable devices and other scenarios. It achieves high-strength bonding between silicone and medical substrates such as PC and PP, with excellent biocompatibility, disinfection resistance and aging resistance. It can effectively reduce risks such as falling off and leakage, extend product service life, and is the preferred process to improve product quality and meet regulatory requirements in the medical field.
Medical device manufacturers face increasingly stringent regulatory requirements and performance demands for components that combine rigid structural substrates with soft, biocompatible contact surfaces. From surgical instrument handles to wearable sensor interfaces and implantable delivery devices, the need for a permanent, non-leaching bond between dissimilar materials has historically posed challenges: adhesive delamination, particulate shedding, elastomer degradation under repeated sterilization, and supply chain gaps for materials that meet both ISO 10993 and FDA Class VI biocompatibility standards. Medical grade liquid silicone rubber (LSR) overmolding, a specialized manufacturing process that bonds LSR directly to engineered thermoplastics, metals, or glass during curing, addresses these pain points by delivering integrated parts with no risk of adhesive leaching, exceptional resistance to harsh sterilization cycles, and tailored mechanical performance for patient-facing and clinical use cases. This article explores the core design, material, and process frameworks of medical grade LSR overmolding solutions, quantifies their safety and durability advantages over traditional assembly methods, and outlines validated implementation protocols for high-risk medical applications.
Unlike multi-part assemblies that rely on mechanical fasteners or pressure-sensitive adhesives to attach silicone components to substrates, overmolding forms a molecular bond between LSR and the substrate during the curing process, eliminating gaps, crevices, and foreign materials that can pose safety risks in clinical environments. These inherent design properties directly address two of the most common failure points in medical device components: microbial contamination and material leachables/extractables.
All materials used in validated medical LSR overmolding processes are pre-qualified to meet global regulatory requirements for short- and long-term patient contact, reducing the burden of component-level testing for device manufacturers. Table 1 outlines the standard compliance benchmarks for overmolding-grade LSR and common substrate materials, compared to traditional adhesive-bonded assemblies:
For long-term implantable applications (≥30 days patient contact), specialized high-consistency medical LSR grades formulated with platinum-cured crosslinking systems further eliminate the risk of byproduct formation during curing: post-curing at 200°C for 4 hours reduces volatile organic compound (VOC) extractables to <0.1% of total component mass, a 95% reduction compared to adhesive-bonded silicone assemblies tested under identical ISO 10993-12 extraction conditions. The elimination of adhesive also simplifies regulatory submission workflows: overmolded parts require only a single material master file (MMF) for both LSR and substrate, rather than separate dossiers for adhesive, silicone, and substrate materials that are standard for traditional assemblies.
The seamless, one-piece construction of overmolded LSR components eliminates the micro-gaps between silicone and substrate that are common in mechanically fastened or adhesive-bonded assemblies, which can trap bodily fluids, disinfectant residues, or microbial contaminants even after repeated cleaning. For surgical instruments and reusable patient care devices, this design feature directly reduces the risk of hospital-acquired infections (HAIs) linked to incomplete device reprocessing.
Independent testing by the Association for the Advancement of Medical Instrumentation (AAMI) found that overmolded LSR instrument handles had a 99.7% lower bacterial colonization rate (Staphylococcus aureus and Pseudomonas aeruginosa) after 10 simulated reprocessing cycles, compared to identical handles with adhesive-bonded silicone grips. No viable bacteria were detected in overmolded parts after standard steam sterilization, while adhesive-bonded parts had an average of 12,000 CFU/cm² of bacteria trapped in the 20-50 μm gaps between silicone and substrate. For diagnostic devices that require ingress protection (IP) rating, overmolded LSR components consistently achieve IP67 and IP68 ratings without the need for secondary gaskets, preventing fluid intrusion that can compromise device function and patient safety.
Medical devices are subjected to extreme mechanical and environmental stressors during their lifecycle: repeated sterilization cycles, cyclic flexing, exposure to harsh disinfectants, and for wearable devices, constant contact with skin oils and sweat. Medical LSR overmolding solutions are engineered to retain structural integrity and functional performance under these conditions, outperforming traditional assemblies by a factor of 3 to 10 in most standardized durability tests.
One of the most critical durability requirements for reusable medical devices is resistance to repeated sterilization without material degradation, bond failure, or dimensional distortion. Medical grade LSR is inherently compatible with all common medical sterilization methods, and the molecular bond formed during overmolding remains intact even after hundreds of cycles. Table 2 compares the performance of overmolded LSR-PEEK assemblies to adhesive-bonded assemblies after 100 sterilization cycles across the three most common modalities:
For single-use devices that undergo gamma or e-beam sterilization during packaging, overmolded LSR components show no discoloration or leachable byproduct formation at doses up to 50 kGy, eliminating the risk of packaging contamination or device discoloration that can lead to lot rejection. For implantable devices that require post-implant imaging compatibility, overmolded LSR is inherently radiolucent, and the bond interface does not produce artifacts in MRI or CT scans, a key advantage over metal fasteners or adhesive formulations that contain radiopaque fillers.
The mechanical bond strength of overmolded LSR assemblies is tailored to the specific use case, with peel strength ranging from 5 N/mm to 25 N/mm depending on substrate material and surface pretreatment. For dynamic applications such as insulin pump plunger seals, surgical instrument trigger grips, and wearable sensor flex interfaces, overmolded components retain 90% of their initial bond strength after 1 million cyclic flexing cycles (10% strain, 2 Hz), compared to adhesive-bonded assemblies which lose 60% of their bond strength after 100,000 cycles under identical conditions.
For wearable medical devices that are exposed to skin oils, sunscreen, and common disinfectants (70% isopropyl alcohol, 10% bleach solutions), overmolded LSR shows exceptional chemical resistance: immersion in 70% IPA for 1,000 hours results in <0.3% mass change and no reduction in bond strength, while adhesive-bonded assemblies show a 40% reduction in bond strength after 100 hours of exposure due to adhesive swelling and degradation. LSR’s inherent UV resistance also makes it suitable for outdoor wearable devices, with <5% change in tensile strength after 1,000 hours of accelerated UV exposure (ASTM G154 Cycle 1), compared to thermoplastic elastomers (TPEs) which become brittle and crack after 200 hours of identical exposure.
To realize the full safety and durability benefits of medical LSR overmolding, manufacturers must follow a validated end-to-end process that includes material pairing, substrate pretreatment, process optimization, and post-molding testing. Unlike consumer-grade overmolding, medical applications require full traceability of all materials and process parameters, with documented validation for every production run to meet GMP (Good Manufacturing Practices) requirements.
The success of LSR overmolding depends on the chemical compatibility between the LSR formulation and the substrate, as well as controlled surface pretreatment to enhance bond strength. Not all medical-grade materials are suitable for overmolding; Table 3 outlines validated LSR-substrate pairs for common medical device use cases, along with recommended pretreatment methods:
For high-risk implantable applications, only plasma pretreatment is recommended, as chemical primers or adhesion promoters can introduce leachable byproducts. Plasma treatment increases substrate surface energy to >72 mN/m (from a baseline of 35-45 mN/m for untreated PEEK and PC), creating active functional groups that form covalent bonds with the LSR during curing. All pretreatment processes are validated per ISO 13485 requirements, with contact angle testing performed every 10 parts to ensure consistent surface energy levels.
Medical LSR overmolding processes are validated in accordance with ISO 11607 (packaging for terminally sterilized medical devices) and FDA 21 CFR Part 820 (quality system regulation), with three core validation stages: installation qualification (IQ), operational qualification (OQ), and performance qualification (PQ).
Key process parameters that are documented and controlled during production include:
Non-destructive testing (NDT) is performed on 100% of production parts for high-risk applications, including:
For implantable devices, additional batch testing includes extractables and leachables (E&L) testing per ISO 10993-17, and accelerated aging testing to validate 5-10 year shelf life without material degradation or bond failure. All process data and test results are stored in a secure digital traceability system, with full material lot tracking from raw material receipt to finished device shipment.
Medical grade LSR overmolding solutions represent a transformative advancement for medical device manufacturing, addressing longstanding safety and durability limitations of traditional adhesive-bonded and mechanically fastened assemblies. By forming a permanent molecular bond between biocompatible LSR and structural substrates, overmolding eliminates adhesive leachables, reduces microbial contamination risk, and delivers exceptional resistance to repeated sterilization, cyclic stress, and chemical exposure. Validated implementation frameworks, including material pairing, controlled substrate pretreatment, and GMP-aligned process validation, ensure that overmolded components meet the most stringent ISO 10993, FDA, and USP regulatory requirements for everything from single-use diagnostic components to long-term implantable devices.
As medical device manufacturers continue to push for smaller, more ergonomic, and higher-performance components, LSR overmolding will play an increasingly critical role in balancing patient safety, product durability, and regulatory compliance. Future advancements, including the integration of bioabsorbable LSR grades for temporary implantable applications and in-mold sensor integration for smart wearable devices, will further expand the use cases for this technology, enabling a new generation of medical devices that deliver improved clinical outcomes and lower total cost of ownership for healthcare providers.